Chapter/Section Purchase

1 Study Coverage
1.1 Vials for COVID-19 Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Vials for COVID-19 Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Middle-borate Borosilicate Glass
1.2.3 Low-borate Borosilicate Glass
1.3 Market by Application
1.3.1 Global Vials for COVID-19 Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Vaccine Manufacturing
1.3.3 Vaccine Researching
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vials for COVID-19 Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Vials for COVID-19 Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Vials for COVID-19 Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vials for COVID-19 Vaccine Sales by Region
2.4.1 Global Vials for COVID-19 Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Vials for COVID-19 Vaccine by Region (2023-2028)
2.5 Global Vials for COVID-19 Vaccine Revenue by Region
2.5.1 Global Vials for COVID-19 Vaccine Revenue by Region (2017-2022)
2.5.2 Global Vials for COVID-19 Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vials for COVID-19 Vaccine Sales by Manufacturers
3.1.1 Global Top Vials for COVID-19 Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Vials for COVID-19 Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vials for COVID-19 Vaccine in 2021
3.2 Global Vials for COVID-19 Vaccine Revenue by Manufacturers
3.2.1 Global Vials for COVID-19 Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Vials for COVID-19 Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vials for COVID-19 Vaccine Revenue in 2021
3.3 Global Vials for COVID-19 Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vials for COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vials for COVID-19 Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vials for COVID-19 Vaccine Sales by Type
4.1.1 Global Vials for COVID-19 Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Vials for COVID-19 Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Vials for COVID-19 Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Vials for COVID-19 Vaccine Revenue by Type
4.2.1 Global Vials for COVID-19 Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Vials for COVID-19 Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Vials for COVID-19 Vaccine Price by Type
4.3.1 Global Vials for COVID-19 Vaccine Price by Type (2017-2022)
4.3.2 Global Vials for COVID-19 Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vials for COVID-19 Vaccine Sales by Application
5.1.1 Global Vials for COVID-19 Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Vials for COVID-19 Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Vials for COVID-19 Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Vials for COVID-19 Vaccine Revenue by Application
5.2.1 Global Vials for COVID-19 Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Vials for COVID-19 Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Vials for COVID-19 Vaccine Price by Application
5.3.1 Global Vials for COVID-19 Vaccine Price by Application (2017-2022)
5.3.2 Global Vials for COVID-19 Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vials for COVID-19 Vaccine Market Size by Type
6.1.1 North America Vials for COVID-19 Vaccine Sales by Type (2017-2028)
6.1.2 North America Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
6.2 North America Vials for COVID-19 Vaccine Market Size by Application
6.2.1 North America Vials for COVID-19 Vaccine Sales by Application (2017-2028)
6.2.2 North America Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
6.3 North America Vials for COVID-19 Vaccine Market Size by Country
6.3.1 North America Vials for COVID-19 Vaccine Sales by Country (2017-2028)
6.3.2 North America Vials for COVID-19 Vaccine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Vials for COVID-19 Vaccine Market Size by Type
7.1.1 Europe Vials for COVID-19 Vaccine Sales by Type (2017-2028)
7.1.2 Europe Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
7.2 Europe Vials for COVID-19 Vaccine Market Size by Application
7.2.1 Europe Vials for COVID-19 Vaccine Sales by Application (2017-2028)
7.2.2 Europe Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
7.3 Europe Vials for COVID-19 Vaccine Market Size by Country
7.3.1 Europe Vials for COVID-19 Vaccine Sales by Country (2017-2028)
7.3.2 Europe Vials for COVID-19 Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vials for COVID-19 Vaccine Market Size by Type
8.1.1 Asia Pacific Vials for COVID-19 Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Vials for COVID-19 Vaccine Market Size by Application
8.2.1 Asia Pacific Vials for COVID-19 Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Vials for COVID-19 Vaccine Market Size by Region
8.3.1 Asia Pacific Vials for COVID-19 Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Vials for COVID-19 Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Vials for COVID-19 Vaccine Market Size by Type
9.1.1 Latin America Vials for COVID-19 Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
9.2 Latin America Vials for COVID-19 Vaccine Market Size by Application
9.2.1 Latin America Vials for COVID-19 Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
9.3 Latin America Vials for COVID-19 Vaccine Market Size by Country
9.3.1 Latin America Vials for COVID-19 Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Vials for COVID-19 Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vials for COVID-19 Vaccine Market Size by Type
10.1.1 Middle East and Africa Vials for COVID-19 Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Vials for COVID-19 Vaccine Market Size by Application
10.2.1 Middle East and Africa Vials for COVID-19 Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Vials for COVID-19 Vaccine Market Size by Country
10.3.1 Middle East and Africa Vials for COVID-19 Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vials for COVID-19 Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Corning
11.1.1 Corning Corporation Information
11.1.2 Corning Overview
11.1.3 Corning Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Corning Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Corning Recent Developments
11.2 Schott AG
11.2.1 Schott AG Corporation Information
11.2.2 Schott AG Overview
11.2.3 Schott AG Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Schott AG Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Schott AG Recent Developments
11.3 SiO2 Materials Science
11.3.1 SiO2 Materials Science Corporation Information
11.3.2 SiO2 Materials Science Overview
11.3.3 SiO2 Materials Science Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 SiO2 Materials Science Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 SiO2 Materials Science Recent Developments
11.4 SGD Pharma
11.4.1 SGD Pharma Corporation Information
11.4.2 SGD Pharma Overview
11.4.3 SGD Pharma Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 SGD Pharma Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 SGD Pharma Recent Developments
11.5 Stevanato Group
11.5.1 Stevanato Group Corporation Information
11.5.2 Stevanato Group Overview
11.5.3 Stevanato Group Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Stevanato Group Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Stevanato Group Recent Developments
11.6 DWK Life Sciences
11.6.1 DWK Life Sciences Corporation Information
11.6.2 DWK Life Sciences Overview
11.6.3 DWK Life Sciences Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 DWK Life Sciences Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 DWK Life Sciences Recent Developments
11.7 Gerresheimer
11.7.1 Gerresheimer Corporation Information
11.7.2 Gerresheimer Overview
11.7.3 Gerresheimer Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Gerresheimer Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Gerresheimer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vials for COVID-19 Vaccine Industry Chain Analysis
12.2 Vials for COVID-19 Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vials for COVID-19 Vaccine Production Mode & Process
12.4 Vials for COVID-19 Vaccine Sales and Marketing
12.4.1 Vials for COVID-19 Vaccine Sales Channels
12.4.2 Vials for COVID-19 Vaccine Distributors
12.5 Vials for COVID-19 Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vials for COVID-19 Vaccine Industry Trends
13.2 Vials for COVID-19 Vaccine Market Drivers
13.3 Vials for COVID-19 Vaccine Market Challenges
13.4 Vials for COVID-19 Vaccine Market Restraints
14 Key Findings in The Global Vials for COVID-19 Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer